Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Digital Technologies

Business & Regulation Digital Technologies

Why You Should Care More About Bioinformatics

| Angus Stewart | 6 min read

Applied correctly, data can do almost anything

Discovery & Development Drug Discovery

AI Versus AMR

| Rob Coker | 8 min read

MIT scientists believe the future is bright for antibiotics discovery

Business & Regulation Digital Technologies

Immunization Versus Ignorance

| Rob Coker | 4 min read

Who do we blame for the return of polio?

Manufacture Contract Manufacturing Services

The Innovation Awards 2022

| 11 min read

It’s December – time for The Medicine Maker to welcome you to 2022’s most innovative new technologies in drug development and manufacturing

Business & Regulation Profession

Pharma and Fordism

| Angus Stewart | 10 min read

Sitting Down With… Gen Li, CEO, Phesi

Manufacture Advanced Medicine

Less Than 5 Percent Human Effort: Thoughts on the Role of Automation on Cell and Gene Therapy

| Dalip Sethi | 7 min read

We all know that automation can reduce human labor, but how else can it make economically viable cell and gene therapies a reality?

Manufacture Small Molecules

It’s Time to Calculate the Carbon Footprint of Pharmaceutical Products

| Bailey Risteen | 6 min read

BASF has put substantial effort into reducing carbon emissions. A key aspect of their strategy lies in extracting and acting upon the right data.

Manufacture Advanced Medicine

Cell and Gene Champions Speak Up

| Angus Stewart

Get a sharp perspective on the cell and gene status quo in The Medicine Maker 2022 supplement on advanced medicine

Business & Regulation Digital Technologies

There’s Nothing Artificial About AI’s Potential in Pharma Research

| Avi Kulkarni | 3 min read

Can AI realistically transform data management in pharma? Yes. And it’s already begun.

Business & Regulation Business Practice

Imposter Twitter Account Loses Eli Lilly Billions

| Stephanie Sutton | 2 min read

Fake tweet announcing free insulin leads to mayhem.


Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register